Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity
about
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsProgesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotectionNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationNeuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury.Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury.The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cellsProgesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced miceEffects of progesterone on glutamate transporter 2 and gamma-aminobutyric acid transporter 1 expression in the developing rat brain after recurrent seizures.Imaging the Insertion of Superecliptic pHluorin-Labeled Dopamine D2 Receptor Using Total Internal Reflection Fluorescence Microscopy.Progesterone blocks multiple routes of ion fluxCorticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged.The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects.Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway.Progesterone Sharpens Temporal Response Profiles of Sensory Cortical Neurons in Animals Exposed to Traumatic Brain Injury.Beta-Estradiol Regulates Voltage-Gated Calcium Channels and Estrogen Receptors in Telocytes from Human Myometrium.
P2860
Q24273391-3F7EE61B-D118-4DE7-84B7-7F9CAC3E3682Q24616548-F665FCED-14DD-4A54-9C12-0978F69E8D30Q26823386-B300FD93-6C5B-40B5-BBAF-CA21057BB441Q30364414-409E02D4-1B3F-434C-A9CD-33599315FBC6Q33630503-59D8EF25-9199-4C4C-84F1-D70A15B75E1EQ33807418-984C9861-2A84-4985-998D-4B2F8FB59997Q34566512-A7898DCB-3855-4403-8E25-C84978C9E984Q34975621-751397B7-7164-4B4A-A2BA-9F016CB006E7Q35013244-7BD2FF13-9ABC-432C-9889-D3237E600611Q35186461-32956519-2F53-449F-B6B4-1EE633E49669Q35201084-ECC14BEF-618C-42C5-B60A-2F96B49E292DQ36177379-0DD9F5B8-5DC3-4C57-BFDF-7431B02D0C39Q37088482-2C5317F2-0176-4DCB-8D11-C1FCFF5820D2Q37372776-E0404486-9E64-4A5B-A195-B48201FD4CDEQ37508249-669F7475-27C0-4258-92A1-7A9445B4DB42Q37678039-526C7BED-3667-4E0E-95D9-A049E8DCE911Q42925565-E4F4F331-3829-4A93-BBC4-1A0B022D46DCQ55261561-FFD39F3B-6E87-4162-9565-D16C63F2835D
P2860
Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Progesterone inhibition of vol ...... chanism against excitotoxicity
@ast
Progesterone inhibition of vol ...... chanism against excitotoxicity
@en
type
label
Progesterone inhibition of vol ...... chanism against excitotoxicity
@ast
Progesterone inhibition of vol ...... chanism against excitotoxicity
@en
prefLabel
Progesterone inhibition of vol ...... chanism against excitotoxicity
@ast
Progesterone inhibition of vol ...... chanism against excitotoxicity
@en
P2093
P2860
P1433
P1476
Progesterone inhibition of vol ...... chanism against excitotoxicity
@en
P2093
Brooke G Kelley
Jessie I Luoma
Paul G Mermelstein
P2860
P304
P356
10.1016/J.STEROIDS.2011.02.013
P577
2011-03-01T00:00:00Z